Tag Archive for: cell and gene therapy

Astraveus further strengthens world class leadership team to advance development of Lakhesys Benchtop Cell Factory™

Highly experienced hires bring robust operational and technical expertise Momentum builds at Astraveus following exceptional additions of Jean-Paul Mangeolle, David Newble, and Laurence Riot Lamotte earlier this year Paris, France, 21 October 2025 – Astraveus SAS (“Astraveus” or the “Company”), the Benchtop Cell Factory company, today announces that it has further strengthened its world class […]

Resolution Therapeutics to host virtual R&D webinar alongside world leading clinical hepatologists Prof. Jonathan Fallowfield and Dr. Elliot Tapper

Resolution leadership team joined by world leading clinical hepatologist Elliot Tapper, MD, FAASLD, and EMERALD Chief Investigator Professor Jonathan Fallowfield Edinburgh and London, UK, 27 August 2025 – Resolution Therapeutics (“Resolution” or “Company”), a clinical-stage biopharmaceutical company pioneering regenerative macrophage therapies to treat inflammatory and fibrotic diseases, today announces that it will host a virtual […]

Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell FactoryTM for CAR-T therapy manufacturing

Agreement with Netherlands Center for the Clinical Advancement of Stem Cell and Gene Therapies (NecstGen) for the manufacturing of CAR-T therapies using Lakhesys Benchtop Cell FactoryTM Partnership to demonstrate the ability of Astraveus’ technology to deliver reduced costs and increased efficiency in CAR-T manufacturing Paris, France, 6 May 2025 – Astraveus SAS (“Astraveus” or the […]

Hot topic: Should Pharma be looking east for new assets?

“Go west, young man!”   Such was the famous advice of Horace Greeley, founder and editor of the (long defunct) New York Tribune, to an acquaintance, Josiah B. Grinnell, in the mid-19th century.  Countless individuals, businesses, and industries have since followed that advice – and gone on to strike gold.  But when it comes to where […]

Astraveus appoints Dr. Lars Henrik Peeck as Chief Business Development Officer

Paris, France, 12 December 2023 – Astraveus SAS (“Astraveus” or the “Company”), the creator of the end-to-end benchtop cell factory to simplify cell and gene therapy (CGT) manufacturing, today announces the appointment of Dr. Lars Henrik Peeck as Chief Business Development Officer. Read more…